
Henry W. Orr
Examiner (ID: 18694, Phone: (571)270-1308 , Office: P/2145 )
| Most Active Art Unit | 2145 |
| Art Unit(s) | 2176, 2172, 2175, 2145 |
| Total Applications | 615 |
| Issued Applications | 272 |
| Pending Applications | 63 |
| Abandoned Applications | 287 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18374219
[patent_doc_number] => 20230149296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTS AND CONTRACEPTIVES
[patent_app_type] => utility
[patent_app_number] => 17/920919
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920919 | DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTS AND CONTRACEPTIVES | Apr 29, 2021 | Pending |
Array
(
[id] => 17981320
[patent_doc_number] => 20220347356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => Endovascular Prostheses
[patent_app_type] => utility
[patent_app_number] => 17/242733
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242733
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242733 | Endovascular Prostheses | Apr 27, 2021 | Abandoned |
Array
(
[id] => 18619120
[patent_doc_number] => 11752142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Oral pharmaceutical compositions of dabigatran etexilate
[patent_app_type] => utility
[patent_app_number] => 17/241793
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6750
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17241793
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/241793 | Oral pharmaceutical compositions of dabigatran etexilate | Apr 26, 2021 | Issued |
Array
(
[id] => 18418515
[patent_doc_number] => 20230172973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING AND COMBATTING TUBERCULOSIS
[patent_app_type] => utility
[patent_app_number] => 17/920099
[patent_app_country] => US
[patent_app_date] => 2021-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920099
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920099 | METHODS AND COMPOSITIONS FOR TREATING AND COMBATTING TUBERCULOSIS | Apr 18, 2021 | Pending |
Array
(
[id] => 18389994
[patent_doc_number] => 20230158212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => COMPOSITE SCAFFOLD MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/912707
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12616
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912707
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/912707 | COMPOSITE SCAFFOLD MATERIAL | Apr 15, 2021 | Pending |
Array
(
[id] => 17168978
[patent_doc_number] => 20210322648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => ELECTROACTIVE BIOCOMPATIBLE HYDROGEL STRUCTURES
[patent_app_type] => utility
[patent_app_number] => 17/230195
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3960
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230195
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/230195 | Electroactive biocompatible hydrogel structures | Apr 13, 2021 | Issued |
Array
(
[id] => 18361340
[patent_doc_number] => 20230142931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => Zinc-Containing Medical Instrument
[patent_app_type] => utility
[patent_app_number] => 17/915430
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10059
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915430
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915430 | Zinc-Containing Medical Instrument | Apr 6, 2021 | Pending |
Array
(
[id] => 18418682
[patent_doc_number] => 20230173141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => NANOFIBER-ENABLED ENCAPSULATION DEVICES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/916215
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916215 | NANOFIBER-ENABLED ENCAPSULATION DEVICES AND USES THEREOF | Apr 1, 2021 | Pending |
Array
(
[id] => 17480422
[patent_doc_number] => 20220087926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => COMPOUND COMPOSITION WITH ANTI-OXIDATION AND ANTI-AGING EFFECTS AND PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/207740
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207740
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/207740 | COMPOUND COMPOSITION WITH ANTI-OXIDATION AND ANTI-AGING EFFECTS AND PREPARATION METHOD AND APPLICATION THEREOF | Mar 21, 2021 | Abandoned |
Array
(
[id] => 17124394
[patent_doc_number] => 20210299162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTION AND/OR IMPROVEMENT OF ENCEPHALITIS AND/OR MENINGITIS AND SYMPTOM ASSOCIATED WITH THE ENCEPHALITIS AND/OR MENINGITIS
[patent_app_type] => utility
[patent_app_number] => 17/206820
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206820
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206820 | MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTION AND/OR IMPROVEMENT OF ENCEPHALITIS AND/OR MENINGITIS AND SYMPTOM ASSOCIATED WITH THE ENCEPHALITIS AND/OR MENINGITIS | Mar 18, 2021 | Abandoned |
Array
(
[id] => 18673217
[patent_doc_number] => 20230310712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/906433
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906433
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/906433 | IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF | Mar 17, 2021 | Pending |
Array
(
[id] => 18418676
[patent_doc_number] => 20230173135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => PROCESS TO COAT A MEDICAL DEVICE SURFACE WITH PEPTIDE-BASED NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/905690
[patent_app_country] => US
[patent_app_date] => 2021-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905690
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905690 | PROCESS TO COAT A MEDICAL DEVICE SURFACE WITH PEPTIDE-BASED NANOPARTICLES | Mar 9, 2021 | Abandoned |
Array
(
[id] => 18348678
[patent_doc_number] => 20230136789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => POLYMER IMPLANTS
[patent_app_type] => utility
[patent_app_number] => 17/905605
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905605
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905605 | POLYMER IMPLANTS | Mar 4, 2021 | Abandoned |
Array
(
[id] => 18254906
[patent_doc_number] => 20230081945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => CROSSLINKED POLY(LACTIDE-CO-GLYCOLIDE) (PLGA)-DIMETHACRYLATE COATINGS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/904553
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3782
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904553
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/904553 | CROSSLINKED POLY(LACTIDE-CO-GLYCOLIDE) (PLGA)-DIMETHACRYLATE COATINGS AND METHODS OF USE | Feb 23, 2021 | Abandoned |
Array
(
[id] => 17050808
[patent_doc_number] => 20210260242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => BIOACTIVE IMPLANTABLE DEVICES, AND COMPOSITE BIOMATERIALS AND METHODS FOR MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/182920
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182920 | BIOACTIVE IMPLANTABLE DEVICES, AND COMPOSITE BIOMATERIALS AND METHODS FOR MAKING THE SAME | Feb 22, 2021 | Abandoned |
Array
(
[id] => 18737928
[patent_doc_number] => 20230346830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => TREATMENT OF A VIRAL PANDEMIC USING CIGARETTES WITH ADDED NITRATES
[patent_app_type] => utility
[patent_app_number] => 17/797608
[patent_app_country] => US
[patent_app_date] => 2021-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17797608
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/797608 | TREATMENT OF A VIRAL PANDEMIC USING CIGARETTES WITH ADDED NITRATES | Feb 14, 2021 | Pending |
Array
(
[id] => 20076362
[patent_doc_number] => 12350397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Superabsorbent, freeze dried hydrogels for medical applications
[patent_app_type] => utility
[patent_app_number] => 17/174476
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 3092
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17174476
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/174476 | Superabsorbent, freeze dried hydrogels for medical applications | Feb 11, 2021 | Issued |
Array
(
[id] => 16868527
[patent_doc_number] => 20210161994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/172821
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172821
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/172821 | IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF | Feb 9, 2021 | Pending |
Array
(
[id] => 18193695
[patent_doc_number] => 20230047214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => METHODS FOR MICROWAVE SYNTHESIS OF DEGRADABLE POLYMERS FOR DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/796925
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796925 | METHODS FOR MICROWAVE SYNTHESIS OF DEGRADABLE POLYMERS FOR DRUG DELIVERY | Feb 2, 2021 | Pending |
Array
(
[id] => 18323798
[patent_doc_number] => 20230121926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => METHODS FOR TISSUE REGENERATION AND KITS THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/914134
[patent_app_country] => US
[patent_app_date] => 2021-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914134
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914134 | METHODS FOR TISSUE REGENERATION AND KITS THEREFOR | Jan 24, 2021 | Pending |